-
-
-
-
-
-
-
Takeda (TAK) and Arrowhead (ARWR) Report Topline Results from SEQUOIA Phase 2 Study of Fazirsiran
-
-
-
-
-
-
-
Takeda (TAK) and Arrowhead (ARWR) Collaborate to Co-Develop and Co-Commercialize ARO-AAT for Alpha-1 Antitrypsin-Associated Liver Disease
-
-
-
-
-
-
-
Live Nation Entertainment, Zebra Technologies, STERIS Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600
-
-
-
-
-
-
-
Arrowhead Pharmaceuticals Announces Proposed Underwritten Offering of Common Stock
-
-
-
-
-
-
-
Arrowhead Pharmaceuticals Corp (ARWR) Prices 10M Common Stock Offering at $5.25/Share
-
-
-
-
-
-
-
Pre-Open Stock Movers 10/06: (ALQA) (SCYX) (ZUMZ) Higher; (ALNY) (TWTR) (MDCO) Lower (more...)
-
-
-
-
-
-
-
Unusual 11 Mid-Day Movers 12/7: (GMCR) (XBIT) (GAI) Higher; (THLD) (BLUE) (VNR) Lower
-
1,158,061 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

